Abstract
The role of lithium as an adjunct to 131I therapy of thyrotoxicosis has been assessed. Seventeen lithium-131I treated patients and 16 control — 131I treated patients have been followed for almost three years. Five lithium — 131I and 3 control — 131l patients have become hypothyroid with the lithium treated patients developing earlier thyroid failure. Ten lithium and 10 control patients remain clinically and biochemically euthyroid. Two lithium — 131I and 2 control — 131I patients remain on low dose antithyroid drugs.
Similar content being viewed by others
References
Burrow G.H., Burke W.R., Himmelhock J.M., Spencer R.P., Hershman J.M. Effect of lithium on thyroid function. J. Clin. Endocrinol. Metab. 32: 647, 1971.
Turner J.G., Brownlie B.E.W., Rogers T.G.H. Lithium as an adjunct to radioiodine therapy for thyrotoxicosis. Lancet 1: 614, 1976.
Sadler W.A., Brownlie B.E.W., Triiodothyronine radioimmunoassay in the assessment of thyroid function. N.Z. Med. J. 81: 320, 1975.
Donald R.A., Brownlie B.E.W., Espiner E.A., Rutledge D. Measurement of pituitary hormones: clinical applications 4. Thyroid stimulating hormone. N.Z. Med. J. 78: 204, 1973.
Chambers S., Brownlie B.E.W., Turner J.G., Macbeth W.A.A.G. Subtotal thyroidectomy for thyrotoxicosis: a reassessment, including TRH responsiveness. N.Z. Med. J. 87: 163, 1978.
Gershengorn M.C., Izumi M., Robbins J., Use of lithium as an adjunct to radioiodine therapy of thyroid carcinoma. J. Clin. Endocrinol. Metab. 42: 105, 1976.
Hedley J.M., Turner J.G., Brownlie B.E.W., Sadler W.A. Low dose lithium-carbimazole in the treatment of thyrotoxicosis. Aust. N.Z.J. Med. 8: 628, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brownlie, B.E.W., Turner, J.G., Ovenden, B.M. et al. Results of lithium-131I treatment of thyrotoxicosis. J Endocrinol Invest 2, 303–304 (1979). https://doi.org/10.1007/BF03350422
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350422